Home » Bayer Launches Eye Drug Syringe in Europe
Bayer Launches Eye Drug Syringe in Europe
April 13, 2020
Bayer has earned the European Medicines Agency’s approval for its pre-filled Eylea (aflibercept) syringe, clearing it for marketing in Europe.
The drug is approved for treatment of neovascular wet age-related macular degeneration (AMD) and for treating visual impairment caused by macular edema.
The marketing approval applies to all EU states in addition to the UK, Iceland, Norway and Liechtenstein.
Upcoming Events
-
21Oct